SEARCH PLATELETNEWS.ORG
Faculty

Glenn N. Levine, MD

Co-Chair
Poll
Do you prescribe dual antiplatelet therapy to patients presenting with acute coronary syndromes on admission?

Educational Links
You need to upgrade your Flash Player
Current Literature

Search Literature Reviews

 Categories
Browse Alphabetically by Author
A-D E-H I-L M-P Q-T U-Z

Keywords



Influence of Aspirin Resistance on Platelet Function Profiles in Patients on Long-Term Aspirin and Clopidogrel After Percutaneous Coronary Intervention

Angiolillo et al.
Am J Cardiol.  2006;97:38-43.
  KEYWORDS: Acute Coronary Syndrome , Aspirin , Cardiovascular , Percutaneous Coronary Intervention , Pharmacologic Therapy

The Incidence and Clinical Predictors of Early Stent Thrombosis in Patients with Acute Coronary Syndrome

Beinart R, Sham’a RA, Segev A, et al.
Am Heart J.  2010;159(1):118-124.
  KEYWORDS: Acute Coronary Syndrome , Stent Thrombosis

Aspirin for the Prevention of Cardiovascular Events in Patients With Peripheral Artery Disease

Berger JS, Krantz MJ, Kittelson JM, Hiatt WR.
JAMA.  2009;301(18):1909-1919.
  KEYWORDS: Aspirin , Cardiovascular , Myocardial Infarction

Incidence, Predictors, and Clinical Impact of Bleeding After Transradial Coronary Stenting and Maximal Antiplatelet Therapy

Bertrand OF, Larose E, Rodes-Cabau J, et al.
Am Heart J.   2009;157(1):164-169.
  KEYWORDS: Percutaneous Coronary Intervention , Pharmacologic Therapy

Intravenous Platelet Blockade with Cangrelor during PCI

Bhatt DL, Lincoff AM, Gibson CM, et al; for the CHAMPION PLATFORM Investigators.
N Engl J Med.  2009; Nov 15. Epub ahead of print.
  KEYWORDS: Cardiovascular
 
Click for Full Abstract

Impact of Optimal Medical Therapy With or Without Percutaneous Coronary Intervention on Long-Term Cardiovascular End Points in Patients With Stable Coronary Artery Disease (from the COURAGE Trial)

Boden WE, O'Rourke RA, Teo KK, et al; for the COURAGE Trial Investigators.
Am J Cardiol.  2009;104(1):1-4.
  KEYWORDS: Percutaneous Coronary Intervention
 
Click for Full Abstract

Antithrombotics in acute coronary syndromes

Bonaca MP, Steg PG, Feldman LJ, et al.
J Am Coll Cardiol.  2009;54(11):969-984.
  KEYWORDS: Acute Coronary Syndrome
 
Click for Full Abstract

Body Mass Index, Periprocedural Bleeding, and Outcome Following Percutaneous Coronary Intervention (From The British Columbia Cardiac Registry)

Byrne J, Spence MS, Fretz E, et al.
Am J Cardiol.  2009;103(4):507-511.
  KEYWORDS: Percutaneous Coronary Intervention

Treatment of Clopidogrel Hypersensitivity Without Drug Interruption: Acute and Long-Term Outcomes

Campbell KL, Mallya R, Jaffrani W, et al.
Presented at: American College of Cardiology; March 29-31, Orlando, Florida.  2009
  KEYWORDS: Percutaneous Coronary Intervention , Pharmacologic Therapy

Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non–ST-segment elevation acute coronary syndrome. Primary results of the DISPERSE-2 Trial

Cannon CP et al.
J Am Coll Cardiol.  2007;50:1844-1851.
  KEYWORDS: Acute Coronary Syndrome , Cardiovascular , Hemorrhage , Myocardial Infarction , Percutaneous Coronary Intervention , Pharmacologic Therapy

Comparison of Ticagrelor With Clopidogrel in Patients With a Planned Invasive Strategy for Acute Coronary Syndromes (PLATO): A Randomized Double-Blind Study

Cannon CP, Harrington RA, James S, et al; for the PLATelet inhibition and patient Outcomes (PLATO) investigators.
Lancet.  2010. Epub ahead of print. DOI:10.1016/S0140-6736(09)62191-7.
  KEYWORDS: Acute Coronary Syndrome

Use of drug-eluting versus bare-metal stents in ST-segment elevation myocardial infarction

Chen SF, El-Bialy A, Matthews R, Clavijo L.
J Invasive Cardiol.  2009;21(11):E206-E212.
  KEYWORDS: Bare-Metal Stents , Drug-Eluting Stents
 
Click for Full Abstract

Dose Effect of Clopidogrel Reloading in Patients Already on 75-mg Maintenance Dose: The Reload with Clopidogrel Before Coronary Angioplasty in Subjects Treated Long Term with Dual Antiplatelet Therapy (RELOAD) Study

Collet J-P, Silvain J, Landivier A, et al.
Circ  2008;118(12):1225-1233
  KEYWORDS: Acute Coronary Syndrome , Percutaneous Coronary Intervention , Pharmacologic Therapy

HDL-Cholesterol Level Provides Additional Prognosis in Acute Coronary Syndromes

Correia LC, Rocha MS, Esteves JP.
Int J Cardiol.  2009;136(3):307-314.
  KEYWORDS: Acute Coronary Syndrome
 
Click for Full Abstract

Aspirin Noncompliance is the Major Cause of “Aspirin Resistance” in Patients Undergoing Coronary Stenting

Cuisset T, Frere C, Quilici J, et al
Am Heart J.   2009;157(5):889-893.
  KEYWORDS: Aspirin , Stent Thrombosis

Eptifibatide Provides Additional Platelet Inhibition in Non–ST-Elevation Myocardial Infarction Patients Already Treated With Aspirin and Clopidogrel: Results of the Platelet Activity Extinction in Non–Q-Wave Myocardial Infarction With Aspirin, Clopidogrel, and Eptifibatide (PEACE) Study

Dalby et al.
J Am Coll Cardiol.   2004;43:162-168.
  KEYWORDS: Acute Coronary Syndrome , Aspirin , Cardiovascular , Myocardial Infarction , Percutaneous Coronary Intervention , Pharmacologic Therapy

The reversible P2Y12 antagonist cangrelor influences the ability of the active metabolites of clopidogrel and prasugrel to produce irreversible inhibition of platelet function.

Dovlatova NL et al.
J Thromb Haemost.  2008;6:1153-1159.
 

Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 trial

Feit et al.
Am J Cardiol.  2007;100:1364-1369
  KEYWORDS: Acute Coronary Syndrome , Cardiovascular , Hemorrhage , Percutaneous Coronary Intervention , Pharmacologic Therapy

Effect of Intensive Statin Therapy on Clinical Outcomes Among Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome

Gibson CM, Pride YB, Hochberg CP, et al; for the TIMI Study Group.
J Am Coll Cardiol.  2009;54(24):2290-2295.
  KEYWORDS: Percutaneous Coronary Intervention

Early Versus Delayed, Provisional Eptifibatide in Acute Coronary Syndromes

Giugliano RP, White JA, Bode C, et al for the EARLY ACS investigators
New Engl J Med.  2009;360(21):2176-2190.
  KEYWORDS: Acute Coronary Syndrome , Aspirin , Myocardial Infarction , Pharmacologic Therapy

Early Versus Delayed, Provisional Eptifibatide in Acute Coronary Syndromes

Giugliano RP, White JA, Bode C, et al, for the EARLY ACS Investigators
N Engl J Med.  2009;360(21):2176-2190
  KEYWORDS: Acute Coronary Syndrome , Percutaneous Coronary Intervention , Pharmacologic Therapy

Initial Experience With an Intravenous P2Y12 Platelet Receptor Antagonist in Patients Undergoing Percutaneous Coronary Intervention: Results From a 2-Part, Phase II, Multicenter, Randomized, Placebo- and Active-Controlled Trial

Greenbaum et al.
Am Heart J.   2006;151:689.e1-689.e10.
  KEYWORDS: Acute Coronary Syndrome , Aspirin , Cardiovascular , Percutaneous Coronary Intervention , Pharmacologic Therapy

A Review of the Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets (CLEAR PLATELETS) and CLEAR PLATELETS 1b Studies

Gurbel et al.
Circulation.   2005;111:1153-1159.
  KEYWORDS: Aspirin , Atherothrombosis , Cardiovascular , Percutaneous Coronary Intervention , Pharmacologic Therapy

Clopidogrel Effect on Platelet Reactivity in Patients With Stent Thrombosis. Results of the CREST Study

Gurbel et al.
J Am Coll Cardiol .  2005;46:1827-1832.
  KEYWORDS: Acute Coronary Syndrome , Atherothrombosis , Bare-Metal Stents , Cardiovascular , Drug-Eluting Stents , Stent Thrombosis

Platelet Inhibition With Cangrelor in Patients Undergoing PCI

Harrington RA, Stone GW, McNulty S, et al.
N Engl J Med.  2009;361. Epub ahead of print.
  KEYWORDS: Percutaneous Coronary Intervention

Incidence of Death and Acute Myocardial Infarction Associated with Stopping Clopidogrel After Acute Coronary Syndrome

Ho PM et al.
JAMA.  2008;299:532-539.
  KEYWORDS: Acute Coronary Syndrome , Aspirin , Atherothrombosis , Cardiovascular , Myocardial Infarction , Percutaneous Coronary Intervention , Pharmacologic Therapy

Impact of the Degree of Peri-Interventional Platelet Inhibition After Loading With Clopidogrel on Early Clinical Outcome Of Elective Coronary Stent Placement

Hochholzer et al.
Am Coll Cardiol.   2006;48:1742-1750.
  KEYWORDS: Acute Coronary Syndrome , Aspirin , Atherothrombosis , Bare-Metal Stents , Cardiovascular , Drug-Eluting Stents , Percutaneous Coronary Intervention , Pharmacologic Therapy

Antiplatelet Therapy in Children

Israels et al.
Thrombosis Res.  2006;118:75-83.
  KEYWORDS: Aspirin , Atherothrombosis , Cardiovascular , Children , Pharmacologic Therapy

Long-term Safety and Efficacy of Drug-Eluting Versus Bare-Metal Stents in Sweden

James SK, Stenestrand U, Lindbäck J, et al, for the SCAAR Study Group.
N Engl J Med.  2009;360(19):1933-1945.
  KEYWORDS: Bare-Metal Stents , Cardiovascular , Drug-Eluting Stents , Myocardial Infarction , Stent Thrombosis

Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial

Kedhi E, Joesoef KS, McFadden E, Wassing J, van Mieghem C, Goedhart D, Smits PC.
Lancet.  2010 Jan 7. [Epub ahead of print]
  KEYWORDS: Drug-Eluting Stents
  
Click for Full Abstract

2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update)

Kushner FG, Hand M, Smith SC, et al.
J Am Coll Cardiol.   2009;54(23):2205-2241.
  KEYWORDS: Acute Coronary Syndrome